Curis (CRIS) Set to Announce Quarterly Earnings on Thursday

Curis (NASDAQ:CRIS) will be posting its quarterly earnings results before the market opens on Thursday, November 14th. Analysts expect Curis to post earnings of ($1.88) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Curis Stock Down 4.6 %

CRIS opened at $4.12 on Wednesday. The stock has a market cap of $24.63 million, a P/E ratio of -0.52 and a beta of 3.35. Curis has a 12 month low of $4.00 and a 12 month high of $17.49. The company has a fifty day simple moving average of $5.11 and a 200 day simple moving average of $7.31.

Analysts Set New Price Targets

Separately, HC Wainwright dropped their price target on Curis from $26.00 to $20.00 and set a “buy” rating on the stock in a research report on Friday, November 1st.

About Curis

Curis, Inc, a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes.